Progenics Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.0013 par value) Underwriting AgreementProgenics Pharmaceuticals Inc • September 15th, 2005 • Pharmaceutical preparations • New York
Progenics Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) 2,500,000 shares (the “Firm Shares”) of Common Stock, $0.0013 par value (“Common Stock”), of the Company. The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. To the extent there are no additional Underwriters listed on Schedule I other than you, the term Underwriters shall mean either the singular or plural as the context requires. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 375,000 shares (the “Additional Shares”) of Common Stock from the Company for the purpose of covering over allotments in connection with the sale of the Firm Shares. The Firm Shares and the Additional Shares are collectively called the “Securities.”
